Oxidized low density lipoprotein (LDL), formed in vivo from presently unknown reactions, may play a role in atherogenesis. In vitro, transition metals such as iron and copper will facilitate LDL oxidation, but these metals are unlikely to exist in free form in normal body fluids. We have explored the possibility that LDL oxidation may be promoted by heme, a physiologically ubiquitous, hydrophobic, iron-containing compound. Indeed, during several-hour incubation, heme caused extensive oxidative modification of LDL; however, such modification requires only minutes in the presence of small amounts of HjO 2 or preformed lipid hydroperoxides within the LDL. Oxidative interactions between heme, LDL, and peroxides lead to degradation of the heme ring and consequent release of heme iron, which further accelerates heme degradation. Coupled (evidently iron-catalyzed) heme degradation and LDL oxidation are both effectively inhibited by hydrophobic antioxidants and iron chelators. That such hemin-induced LDL oxidation may be involved in atherogenesis is supported by the finding that LDL oxidized by hemin is extremely cytotoxic to cultured aortic endothelial cells. Overall, these investigations not only lend support to the idea that LDL oxidation by physiological substances such as heme may play a role in the process of atherogenesis but also may have broader implications, as similar oxidative reactions between heme and unsaturated fatty acids may occur consequent to hemorrhagic injury. (Arteriosclerosis and Thrombosis 1991;ll:1700-1711)
O xidized low density lipoprotein (LDL) exerts several potentially atherogenic effects. 1 -3 Thus, oxidized LDL 1) is chemotactic for monocytes (but not neutrophils); 2) is rapidly taken up by macrophages through the "scavenger" receptor on these cells, reproducing in vitro the appearance of atherosclerotic plaque foam cells; and 3) is cytotoxic to endothelial cells. Furthermore, antioxidants that inhibit LDL oxidation prevent fatty streak formation in rabbits and are associated with protection against coronary artery disease in population studies. 4 " 6 However, the mechanisms responsible for LDL oxidation in vivo are by no means clear. Most in vitro studies demonstrating presumed atherogenic effects of oxidized LDL have employed prolonged (> 24-hour) incubations of native LDL with distinctly nonphysiological oxidizing systems to produce the altered LDL capable of provoking foam cell production and chemotaxis of monocytes.
One maneuver often employed for in vitro oxidation of LDL is exposure to added transition metals, which will amplify LDL oxidation in serum-free medium. However, in vivo the two most abundant transition metals, iron and copper, are unlikely to exist in free form in normal plasma or interstitial fluids. In the present work, we have explored the possibility that hemin may represent a more likely physiological mediator of LDL oxidation in vivo. Hemin is a ubiquitous iron-containing compound that will spontaneously assort into hydrophobic matrixes. For example, free hemin rapidly accumulates in the membranes of intact cells. That is, we have found that the plasma membranes of intact cultured endothelial cells rapidly accumulate hemin and become extraordinarily susceptible to oxidant damage caused by activated inflammatory cells or soluble H 2 O 2 . 7 Moreover, the iron moiety of hemin is important in this injury; iron-free protoporphyrin or tin-substituted protoporphyrin does not promote endothelial killing. Furthermore, lipid-soluble iron chelators, such as the 21-amino steroid "lazaroids," completely prevent oxidant injury catalyzed by hemin incorporation.
In light of these prior observations, we hypothesized that hemin, a physiologically ubiquitous iron compound, might similarly augment the oxidation of LDL. In a partial test of this hypothesis, we found in the present studies not only that hemin directly promoted oxidative modification of LDL but also that such oxidation was greatly accelerated by small amounts of added H 2 O 2 or by endogenous preformed LDL lipid hydroperoxides. During these oxidative reactions between hemin, LDL, and peroxides, the heme ring was degraded, with the resultant release of free iron. This "coupled oxidation" likely occurs within lipid domains because lipid-soluble antioxidants or iron chelators are more inhibitory of the process than are watersoluble ones. Perhaps most importantly, hemininduced oxidation produces an LDL molecule that is cytotoxic for vascular endothelium. Overall, our results lend support to the idea that LDL oxidation by more physiological substances such as hemin may play a role in the process of atherogenesis.
Methods

Materials
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum, and Hanks' balanced salt solution (HBSS) were obtained from GIBCO (Grand Island, N.Y.); minimum essential medium was from Hazleton (Lenexa, Kan.); collagenase type I was from Worthington (Freehold, NJ.); heparin was from LyphoMed (Melrose Park, 111.); H 2 O 2 was from Fischer Scientific (Pittsburgh, Pa.); 6% hetastarch (hydroxyethylstarch) was from DuPont (Wilmington, Del.); deferoxamine was from CIBA-GEIGY (Basel, Switzerland); chromium-51-labeled CrO 4 (as the sodium salt) was from Amersham (Arlington Heights, 111.); cadmium acetate and cyclohexane were from Aldrich Chemical Co., Inc. (Milwaukee, Wis.); chloroform was from EM Science (Gibbstown, N.J.); KBr was from Fisher Scientific (Fair Lawn, NJ.); FeCl 3 and FeSO 4 were from Mallinckrodt Inc. (Paris, Ky.); Ar was from Northern Cryogenics (St. Paul, Minn.); protoporphyrin DC was from Porphyrin Products (Logan, Utah); bovine hemin type I, butylated hydroxytoluene (BHT), catalase (EC 1.11.1.6; 14,100 units/mg protein), cumene hydroperoxide, dimethyl sulfoxide, essentially fatty acid-free human and bovine serum albumin, EDTA, ferrozine, fluorescamine, Folin and Ciocalteu's phenol reagents, Af-2-hydroxyethylpiperazine-W-2-ethanesulfonic acid (HEPES), human haptoglobin, lauryl sulfate, L-rysine, Percoll, 4/3-phorbol-12-myristate-13-acetate (PMA), KI, K 3 Fe(CN) 6 
Methods
Preparation of human low density lipoprotein. Plasma LDL (1.025-1.050 g/ml density) was prepared from EDTA (1 mg/ml)-anticoagulated venous blood of healthy humans after a 2,000g centrifugation of blood at 4°C for 20 minutes. 8 The plasma density was adjusted to 1.025 g/ml with a KBr solution of 1.346 g/ml density and ultracentrifuged at 100,000g at 4°C for 24 hours. The centrifuged tubes were sliced with a rube slicer, and the bottom fraction was saved. The density of this fraction was then increased from 1.025 g/ml to 1.050 g/ml with a KBr solution. After another 24-hour ultracentrifugation at 100,000g at 4°C, the tubes were sliced again, and the top fraction was saved (usually 20 ml from 100 ml blood) and diafyzed in dialysis tubing (molecular weight, 12,000-14,000) against 4 1 of cold, degassed, N 2 -saturated HEPES-NaCl (10-150 mM) buffer (pH 7.4) in the dark for 8 hours, repeated three times. The dialyzed LDL solution was sterilized by passage through a Millipore filter (0.2 ^m), stored in a sterile plastic tube under Ar in the dark at 4°C, and used within 2 weeks. The protein content was determined by the Peterson-Lowry method with bovine serum albumin as a standard. 9 Oxidation of low density lipoprotein. LDL was oxidatively modified in HBSS (supplemented with 4 mM NaHCO 3 to provide physiological pH) for the neutrophil (polymorphonuclear leukocyte [PMN])-mediated oxidation and the porcine aortic endothelial cell (PAEC) killing experiments. HEPES-NaCl (10-150 mM) buffer (pH 7.4) was used in all other studies. The oxidation was initiated by H 2 O 2 or by PMAactivated PMNs. Alternatively, 1 mM FeSO 4 , FeCl 3 , and CuSO 4 stock solutions were prepared in distilled water just before the experiments and were used immediately to catalyze the LDL oxidation. A 1 mM hemin stock solution was made fresh in 20 mM NaOH and then diluted to the desired concentrations with the reaction buffer. The protoporphyrin IX was prepared in the same way as hemin. The LDL oxidation was performed at 37°C for 3 hours, but in some experiments different incubation times and room temperatures were used. The hydrophobic antioxidants, U74500A (a 21-amino steroid lazaroid), BHT, probucol, and vitamin E, were dissolved in ethanol to a concentration of 50 mM. For U74500A, pH 3 was used to improve solubility. These freshly prepared stock solutions were further diluted to the desired final concentrations with the reaction buffers. The final concentration of ethanol was kept below 0.2%, a concentration without any effect in the system. 600 /A thiobarbituric acid reagent (0.375 g 2-thiobarbituric acid, 2.08 ml 12N HC1, 15 ml 100% trichloroacetic acid, and distilled water to a final volume of 100 ml). After heating at 100°C for 15 minutes, the samples were cooled to room temperature and were centrifuged at 10,000g for 10 minutes. The clear supernatants were analyzed spectrophotometrically at 532 nm, using an extinction coefficient of 1.56 x 1$ M" 1 • cm" 1 , 10 and the results are presented as nanomoles thiobarbituric acid-reactive substances (TBARS) per milligram LDL protein.
Lipid peroxidation assays.
MEASUREMENT OF THIOBARBITURIC
MEASUREMENT OF TOTAL LIPID HYDROPEROXIDES
BY IODOMETRIC METHOD. LDL samples (1 ml) (usually 500 Mg/ml LDL protein concentration) were mixed with 0.1 mM EDTA and vortexed with 3 ml chilled chloroform/methanol (2:1, vol/vol). A 1-ml aliquot of the organic layer was evaporated to dryness under N 2 , layered with Ar, and kept in the dark. Deaerated acetic acid/chloroform (0.6 ml; 3:2, vol/ vol) was added to each sample at 25°C for dissolving the extract, and then 40 /A KI (1.2 g/ml in deaerated distilled water) was added. After a 5-minute incubation in the dark at room temperature, the reaction was stopped by adding 1.8 ml 20 mM cadmium acetate. The clear aqueous phase was spectrophotometrically analyzed at 353 nm after centrifugation of samples at 2,000g for 10 minutes. All readings were corrected for LDL-free blanks. Results were calculated by using an extinction coefficient of 2. A 0.5-ml aliquot of the organic layer of 500 /Ag/ml LDL protein of the chloroform/methanol extract was evaporated to dryness under N 2 . One milliliter of cyclohexane was added to each sample, and the optical density was read at 234 nm. The absorbance was corrected for LDL-free blanks. 13 The conjugated diene formation in unextracted LDL was measured by directly reading the optical density at 234 nm. In these series of experiments the LDL concentration was 100 Mg/ml in HEPES-NaCl buffer.
Measurement of fluorescamine-reactive amino group content of low density Upoprotein. Reactive amino groups in LDL were estimated with fluorescamine with the use of lysine as a standard.
14 After LDL oxidation, 200 /xl 1 mM fluorescamine in acetone was added to 800 ^1 LDL sample in HEPES-NaCl buffer during vortexing. The final LDL protein concentration was 50 /xg/ml. The fluorescence intensity was determined on a Perkin-Elmer spectrofluorometer at 390 nm excitation and 475 nm emission wavelengths after 30 minutes' room-temperature incubation in the dark. LDL-free samples were used as blanks. The results are expressed as moles reactive amino group per mole LDL protein. The molecular weight of LDL protein (apoprotein B-100) was assumed to be 550,000 d. 15 Electrophoretic methods. Electrophoretic mobility was determined by 0.6% agarose gel electrophoresis in 50 mM barbital buffer (pH 8.6). 16 Lipoproteins were visualized by staining with 0.1% (wt/vol) fat red 7B in 95% methanol.
Hemin and iron determinations. HEMIN DETERMINATION. Hemin was measured spectrophotometrically as a hemin-pyridine complex. Pyridine (0.35 ml) and 0.15 ml 1.0N NaOH were added to 1.25 ml 200 p,g/ml LDL samples. After vortexing, the samples were divided into two equal parts. The first one was oxidized by 25 /xl 3 mM K3Fe(CN) 6 , and the second was reduced by 1 mg dithionite. The absorbances were measured at 541 and 557 nm, respectively, using the oxidized samples as blanks. For calculation of the results, the differences between optical densities at 541 and 557 nm were used, with the extinction coefficient of 2.07 x 10 4 M" 1 • cm" 1 .
17
- 18 The results are given as micromoles per liter hemin concentration.
IRON DETERMINATION. Iron was measured spectrophotometrically as a ferrozine-iron complex in a reducing environment. One half milliliter of 200 /ig/ml LDL sample was added to 2 ml iron buffer reagent (1 M acetate buffer, pH 4.5, contains 3% lauryl sulfate, 170 mM ascorbic acid, and 5.3 mM Na 2 S 2 O 5 ). After vortexing and a 15-minute incubation at 37°C, the absorbance at 562 nm was measured for the calculation of the blank value. 19 During the second phase of the procedure, 100 fil ferrozine reagent (9 mM ferrozine and 328 mM thiourea in distilled water) was added to the 2.5-ml samples, and after another 15 -minute incubation time at 37°C, the optical density at 562 nm was measured. The iron concentration was calculated using the extinction coefficient 2.
. 20 The results are given as micromoles per liter iron concentration.
Hemin degradation as a measure of the induction interval time (lag time) of low density lipoprotein oxidation. The kinetics of oxidation of LDL were continuously monitored by the absorbance of hemin at an optical density at 405 nm in a 96-well microtiter plate reader (Molecular Devices Corp., Menlo Park, Calif.) at room temperature for 4 hours. The LDL protein concentration was 100 jtg/ml in HEPESNaCl buffer, pH 7.4. The oxidizing agent was 50 fiM H 2 O 2 , and the initial hemin concentration was 2. 5 .M. The lag time for LDL oxidation was measured as the time required after hemin addition for rapid hemin degradation to occur (as measured by loss of absorbance at 405 nm). This lag time represents the induction phase of LDL oxidation. The results are expressed as minutes of induction phase. For the LDL oxidation-inhibition studies, concentrations of exogenous antioxidants or iron chelators, which were necessary to increase the interval time of the induction phase (lag time) by twofold or fourfold, were assessed. The exogenous antioxidants were added to the LDL samples at 37°C for 15 minutes before hemin administration.
Preparation of human neutrophils. PMNs were isolated from human volunteers after informed consent (following the guidelines of the Committee on the Use of Human Subjects in Research of the University of Minnesota). Briefly, 40-ml blood samples were drawn into plastic syringes containing 20 ml 6% hetastarch in 0.9% NaCl and 200 units of preservative-free heparin. 21 The mixture was allowed to sediment at room temperature for 30-45 minutes, and the supernatant was collected and centrifuged (400g for 5 minutes at 4°C). The pellet was resuspended in • 15 ml ice-cold water, and after 25 seconds, isotonicity was restored by addition of 3.6% NaCl. This suspension was centrifuged at 400g for 5 minutes, the pellet was resuspended in 5 ml HBSS, layered on top of Percoll at 1.075 g/ml specific gravity, and then centrifuged at 20,00% for 30 minutes at 4°C. The resulting PMNs were washed twice again, counted, and assessed by Trypan blue exclusion for viability. Greater than 98% viability and less than 1% platelet contamination were uniformly achieved.
Isolation and culture of porcine aortic endothelial cells. PAECs were isolated enzymatically from porcine aorta by use of type I collagenase (0.2%) for 15 minutes at 3TC. 72 Primary cells were grown in DMEM containing 10% (vol/vol) heat-inactivated fetal calf serum, penicillin (100 units/ml), and streptomycin (100 units/ml) supplemented with L-glutamine at 37°C in 5% CO 2 . Endothelial cells were identified by their morphology and ability to take up acetylated LDL. 23 The cells were subcultured after resuspension by brief exposure to 0.05% trypsin-0.53 mM EDTA and then grown to confluence in 24-well (2-cm 2 wells) culture plates (CoStar, Cambridge, Mass.). The cultures were used from passages four to 10 and studied within 48 hours of reaching confluence.
Porcine aortic endothelial cell cytotoxicity assays. The control cells were incubated with 500 /il HBSS, and the others were incubated with normal or oxidatively modified LDL in HBSS. The 8-hour cytotoxicity assays were performed at 37°C in a humidified atmosphere of 95% air, 5% CO 2 . At the end of the incubation the reaction solution was removed, the monolayer was washed two times with 0.5 ml HBSS, and the combined washes from each well were centrifuged at l,000g for 10 minutes. The radioactivity of the supernatants, the pellets, and the NaOH-lysed (adherent) endothelial cells were measured separately in a gamma counter, generating specific cytotoxicity values, calculated as previously described 24 ; spontaneous 51 Cr release was less than 30% in all experiments.
In the cytotoxicity inhibition experiments, LDL oxidation was inhibited with different agents during the 3-hour hemin-H 2 O 2 modification, and the endothelial cell killing assays were performed with these LDL samples.
Statistics
Significance of differences was determined by Student's t test.
Results
Hemin Catalyzes Low Density Lipoprotein Oxidation
During long-term incubations, hemin greatly enhanced the oxidation of LDL. As shown in Table 1 , the addition of small amounts of hemin (10 fiM) led to large increases in the formation of TBARS, total lipid hydroperoxides, and conjugated dienes after 24 hours of incubation. In fact, in most respects this hemin-catalyzed LDL oxidation was approximately equal to that caused by added copper (also in a concentration of 10 pM). In both cases, near-maximal oxidation of LDL may be occurring; the simultaneous addition of both hemin and H 2 O 2 caused little increase in LDL oxidation (Table 1 ). In contrast with the substantial LDL oxidation caused by addition of either hemin or copper, similar incubations of the starting material with no additives or with H 2 O 2 alone generated insignificant oxidation (Table 1) . This was probably due to the fact that the LDL used in these studies was prepared under conditions designed to minimize spontaneous oxidation. As shown in Figure 1 , the kinetics of LDL oxidation by hemin alone were characterized by a lag phase lasting more than 3 hours (open circles) (as measured by TBARS formation). In contrast, hemincatalyzed LDL oxidation proceeded quite rapidly (with a lag time of only 20 minutes) with the coaddition of 100 fiM H 2 O 2 (closed circles). Indeed, in such short-term incubations the combination of hemin and H 2 O 2 caused at least 50% as much LDL oxidation as did the addition of copper (data not shown). This shortening of the lag time by added H 2 O 2 likely reflects the coupled nature of the oxidation (LDL plus hemin plus oxidant). Hemin-H 2 O 2 -dependent LDL oxidation was also dependent on the hemin concentration ( Figure 2A ). As little as 1 /xM hemin significantly increased TBARS production in the presence of 100 juM H 2 O 2 . Similarly, even smaller concentrations of H 2 O 2 (10 fiM)-in the presence of 5 fiM hemin-were strikingly effective in accelerating LDL oxidation ( Figure 2B ).
Mechanism of Hemin-Mediated Low Density Lipoprotein Oxidation
Although in other systems transition metals markedly enhance lipid peroxidation, chelates of these metals are often far less effective. In the present instance, we suspected that iron, while still bound to hemin, might not be as active as the free metal in catalyzing LDL oxidation. Surprisingly, however, as shown in Figure 3 , "free" iron (added as FeSO 4 or FeQ 3 , 5 fiM) did not induce LDL oxidation even in the presence of H 2 O 2 . Furthermore, iron-EDTA or iron-ADP in similar concentrations did not promote LDL oxidation (data not shown). These observations indicate that although free iron is probably an important catalyst of hemin-induced LDL oxidation because iron-deficient protoporphyrin DC is ineffective, the catalytically active iron is likely delivered by the hemin into hydrophobic compartments normally inaccessible to externally added free iron or hydrophilic iron chelates. Indeed, subsequent experiments provided evidence for the breakdown of LDL-associated hemin and the release of heme iron (this study).
During the oxidation of LDL with hemin and H 2 O 2 , the brownish color typical of hemin gradually disappeared, reflecting coincident hemin destruction. In fact, it was previously shown by others that lipid hydroperoxides can mediate the disintegration of the hemin ring. 25 In the present system, the disintegration of the hemin moiety was made evident by the decrease in hemin absorption at 412 nm, as shown in Figure 4A . Practically all hemin disappeared within 30 minutes in incubations containing added H 2 O 2 (solid circles). This rapid destruction of hemin was not seen in samples containing hemin without added H 2 O 2 . Furthermore, the oxidative destruction of hemin depended on the simultaneous presence of LDL and H 2 O 2 ; in the absence of LDL, hemin was only slowly destroyed by H 2 O 2 (100 fiM), with only 10% being degraded over 3 hours (data not shown). These observations imply that H 2 O 2 may promote hemin-dependent LDL oxidation, at least in part, by facilitating the oxidative destruction of the hemin group, leading perhaps to the release of free catalytically active iron. The importance of this degradation is emphasized by the fact that conjugated diene formation occurred in parallel with the destruction of hemin ( Figure 4A ).
Hemin-dependent LDL oxidation was not absolutely dependent on added H 2 O 2 . As shown in Figure  4B , when LDL was minimally modified by storage (under atmospheric O 2 ) at 4°C, added hemin readily promoted LDL oxidation even in the absence of H 2 O 2 . In this case, hemin disappeared within minutes, presumably via reaction with preformed LDL lipid hydroperoxides, and the loss of intact hemin again coincided with conjugated diene formation.
As might be expected, the (probably oxidative) destruction of intact hemin results in the release of free iron ( Figure 5 ). Both hemin destruction and the attendant release of ferrozine-trappable free iron evidently involved LDL oxidation because the addition of the antioxidant BHT stabilized the heme ring and prevented the release of free iron. 
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The importance of iron released from LDL-associated hemin is further emphasized by the findings that deferoxamine (a potent hydrophilic iron chelator) and the lazaroid U74500A, 26 -27 a hydrophobic antioxidant and weak iron chelator, retarded hemin-H 2 O 2 -mediated lipid peroxidation ( Figure 6 ); consistent with its ability to insert into the hydrophobic milieu of the LDL particle, the hydrophobic "lazaroid" compound was 10-fold more effective than deferoxamine in retarding lipid peroxidation.
Because antioxidants and iron chelators seemingly play an important role in limiting LDL oxidation, a variety of other drugs and natural antioxidants were tested for their ability to retard the induction of LDL oxidation by hemin and hydrogen peroxide. As shown in Table 2 , the lag time necessary for hemin disappearance, closely associated with the induction phase of LDL lipid peroxidation, was used as a measure of LDL resistance to oxidation. With this assay, U74500 is by far the most potent protectant, whereas probucol, an antioxidant used in patients with hypercholesterolemia, is modestly so. Moreover, both bilirubin and vitamin C also prolonged the induction phase for hemin degradation and did so at physiological concentrations. Vitamin E, on the other hand, was not nearly so effective, nor was it as effective as the iron chelator, deferoxamine, or the antioxidant BHT in prolonging the induction phase of lipid peroxidation.
The requirement for intimate association between LDL and hemin in LDL oxidation is supported by experiments employing hemopexin. This serum protein, present in remarkably high plasma concentrations (=75 mg/dl), 28 binds hemin with extraordinary avidity and is likely to prevent insertion of hemin into LDL. Indeed, as shown in Figure 7 , hemopexin added in stoichiometric amounts with hemin almost completely inhibited TBARS production from LDL induced by H 2 O2-hemin. The specificity of this effect is indicated by the observations that equimolar concentrations of haptoglobin (specific for binding hemoglobin) and albumin (which has only weak affinity for free hemin) do not protect LDL from hemincatalyzed peroxidation.
Consequences of Hemin-Catatyzed Low Density Lipoprotein Oxidation
Hemin and H 2 O 2 not only modify the lipid moiety of LDL but also denature its protein as well. LDL exposed to various combinations of hemin, H 2 O 2 , or copper underwent considerable alteration in mobility when assayed by agarose gel electrophoresis ( Figure  8 ). LDL incubated with hemin and H 2 O 2 for 3 hours manifested increased anodal mobility, which increased markedly after incubation for 24 hours to that noted with copper-treated LDL. The increased mobility suggests a loss of net positive charge, which can also be assayed independently by measurement of free amino groups on the LDL particle. As shown in Figure 9 , fluorescamine-titratable free amino groups progressively decreased in LDL incubated with hemin and H 2 O 2 . Moreover, LDL that was already slightly peroxidized reacted with hemin even more rapidly and lost free amino groups without added exogenous H 2 O 2 (open squares).
In vivo, inflammatory cells may play a role in LDL oxidation and vascular injury. We have previously shown 7 that exposure of endothelial cells to free hemin potentiates damage mediated by granulocytes and toxic O 2 species. Oxidant-producing PMA-stimulated neutrophils were therefore tested for their ability to modify LDL. Hemin plus PMA-activated PMNs potently provoked LDL oxidation (Figure 10 ). Conversely, hemin or activated PMNs alone did not cause LDL lipid peroxidation over 3 hours.
Also potentially relevant to in vivo vascular damage are studies demonstrating that copper or celloxidized LDL can be directly cytotoxic to endothelium. As shown in Figure 11 , hemin-exposed LDL also damaged endothelial cells (Figure 11 A) , and LDL oxidation was required for this toxicity. That is, if LDL oxidation was inhibited by diverse reagents including U74500A, BHT, probucol, or catalase, endothelial cells were no longer damaged ( Figure 11B ).
Discussion
The present studies demonstrate that small amounts of free hemin in the presence of H 2 O 2 or activated PMNs catalyze the rapid peroxidation of LDL to substances highly cytotoxic for endothelial cells. Previous studies of LDL oxidation in vitro have generally used prolonged (24 hours or more) periods of aerobic incubation to provoke LDL oxidation. Hemin strikingly shortens the time required for potentially pathophysiological alterations in the LDL particle to occur. In fact, studies shown in Figure 1 suggest that maximal lipid peroxidation, which is also (10-150 mM) Results represent mean±SEM of four experiments performed in duplicate.
FIGURE 6. Semilog plot of inhibition of hemin-HiOrmediated low density lipoprotein (LDL) lipid peroxidation by U74500A "lazaroid" and deferoxamine (DF). LDL (200 tiglmt) (asprotein) in HEPES-NaCl
Low density lipoprotein (LDL) (100 fig/m\ ) was oxidized by 2.5 fiM hemin and 50 AM H 2 O 2 in HEPES-NaCI (10-150 mM) buffer, pH 7.4, at room temperature, and peroxidation was followed by measuring hemin absorbance optical density at 405 nm. Duration of the induction phase was derived from the intersection time point of the linear slopes of the induction phase and the propagation phase. Control value was 31.25±2.39 minutes (mean±SEM, four experiments).
HEPES, Af-2-hydroxyethylpiperazine-/v"-2-ethanesulfonic acid; BHT, butylated hydroxytoluene.
accompanied by hemin degradation and free inorganic iron release, may occur within 20-60 minutes of coincubation.
The results of several independent assays of LDL oxidation all support the conclusion that hemin very efficiently promotes LDL oxidation. Thus, the "traditional" assay of lipid peroxidation-production of TBARS-was correlated closely with other measures of lipid peroxidation including conjugated diene formation, iodometrically assayable lipid hydroperoxide generation, and loss of reactive amino groups. This latter alteration may have direct pathophysiological significance in atherogenesis, as the binding of short-chain fatty aldehydes (released during lipid peroxidation) to lysine e-amino groups of LDL has been shown to foster LDL uptake by scavenger receptors of macrophages, with formation of foam cells. 1 In addition, these aldehyde-LDL adducts have been shown to be highly immunogenic, 29 suggesting that uptake of such altered LDL by macrophages could also occur through macrophage immunoprotein receptors. The importance of hemin-derived iron in promoting LDL oxidation is supported by the observation that iron-deficient "heme" (protoporphyrin IX) has no amplifying effect (Figure 3) . Furthermore, release of inorganic iron from hemin, as detected by ferrozine binding, occurs concomitantly with LDL oxidation ( Figure 5 ). Such iron release is prevented by the potent antioxidant BHT, which concomitantly prevents LDL oxidation as well as generation of material cytotoxic for endothelium. Interestingly, FeSO 4 and FeCl 3 are unable to oxidize LDL ( Figure  3 ), suggesting the need for a hydrophobic "trafficking" molecule to insert the iron into the lipid milieu of the LDL particle. It seems likely that hemin and/or its released iron act in the hydrophobic domains of the LDL molecule to promote oxidation, as lipidsoluble BHT as well as the 21-amino steroid lazaroid, U74500A, are much more potent inhibitors of heminmediated LDL oxidation than the highly avid but relatively lipid-insoluble iron chelator, deferoxamine ( Figure 6 and Table 2 ). Similarly, others have demonstrated that probucol, which is carried in the LDL particle, inhibits LDL oxidation during prolonged aerobic incubation in vitro and inhibits development of atherosclerosis in LDL receptor-deficient (Watanabe) rabbits as well. 4 In the present studies, we report that probucol is also effective in inhibiting hemin-stimulated LDL oxidation but is less potent in this regard than the lipid-soluble lazaroids. This suggests that the latter might be worth testing in animal models of atherogenesis.
The small amounts of H 2 O 2 (10 jtM) ( Figure 2B ), which were shown in the present studies to efficiently promote rapid LDL oxidation in the presence but not absence of hemin, are far less than those previously calculated to exist in the interspace between a marginated activated neutrophil and the endothelial surface. 30 In fact, in the presence of hemin, activated PMNs themselves are highly effective in promoting LDL oxidation, possibly mimicking in vivo events at vascular wall surfaces. We emphasize that the level of LDL oxidation provoked by these modest amounts of soluble or PMN-generated oxidants in the presence of hemin is equivalent to that catalyzed by addition of high concentrations of inorganic copper (Tables 1  and 2 ), which are far in excess of those extant in vivo. Moreover, it seems evident that plasma copper, because of its avid binding to ceruloplasmin, would unlikely act as a catalyst of LDL oxidation in vivo. Instead, we suggest that the initial intercalation of hemin into the lipid domain of LDL, with subsequent release of its free iron in that environment, might avert iron chelation by its binding protein, transferrin, thereby permitting efficient catalysis of lipid oxidation.
Nevertheless, the process of hemin-mediated LDL oxidation is clearly not a simple one and probably involves presently uncharacterized coupled oxidative interactions between LDL, hemin, exogenous oxidants, hemin-derived iron, and endogenous antioxidants. These complex reactions may include 1) spontaneous insertion of the hemin into LDL, 2) subsequent oxidative scission of the porphyrin ring, 3) release of free iron from the heme ring, and 4) iron catalysis of oxidation of further hemin groups, LDL fatty acids, and proteins (Figures 8 and 9 ). The precise nature of the iron catalysis of LDL fatty acid peroxidation is not presently clear. companied by an oxidative destruction of hemoglobin heme) and is catalyzed largely by Fe 2+ formation engendered by endogenous neuronal ascorbate. 33 Once the process is initiated, our results demonstrate that LDL oxidation is autocatalytic. That is, minimally modified LDL produced by simple in vitro storage becomes markedly susceptible to oxidation by hemin alone without the addition of other exogenous oxidants such as H 2 O 2 or PMNs ( Figures 4B and 9 ). Previous studies have demonstrated that the LDL in the artery walls of patients with atherosclerosis is already peroxidized. 34 - 35 Hemorrhage, which may occur with plaque fracture, may provide hemin that could markedly accelerate further vessel wall injury.
These studies may have broader implications when one considers the possibility that similar heminmediated reactions may occur during 1) hemorrhagic injury, especially to the lipid-rich central nervous system; 2) acute intravascular hemolysis, which may lead to renal damage and failure; and 3) various inflammatory processes, such as arthritic joint damage due to recurrent hemorrhage into joint tissues, as is seen in hemophiliacs.
We conclude from the present studies (together with our previous observation 7 that hemin is rapidly incorporated into and oxidatively damages endothelium) that hemin constitutes a significant danger to vascular integrity. Not only may hemin directly render the vascular endothelium hypersusceptible to oxidant injury, but by its ability to intercalate into LDL particles and catalyze their oxidation, it may also promote foam cell production and thereby the formation of the early fatty streak lesions of atherosclerosis. It is tempting to speculate that local accumulation of hemin from trivial hemolysis in areas of turbulent red blood flow in major blood vessels-for instance, at vessel bifurcations -may provoke both enhanced endothelial damage and oxidation of LDL with its hypothesized ramifications for atherogenesis; together, these phenomena may help explain the propensity of atherosclerotic lesions to be found at these sites. It seems ironic that although heme-based proteins undoubtedly evolved as a significant advance in the control of O 2 delivery to tissues, they also can provoke oxidant sensitivity of endothelium and LDL; by doing so, they may worsen and may even engender atherosclerotic damage. The remarkably large concentrations of plasma hemopexin (approximately 75 mg/dl) may be an evolutionary tribute to the clear and present danger posed by free hemin.
